{"filing":{"accession_number":"0001635088-26-000060","cik":"0001635088","ticker":"ROIV","company_name":"Roivant Sciences Ltd.","form":"8-K","filing_date":"2026-05-20","report_date":null,"primary_document":"roiv-20260520.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1635088/000163508826000060/roiv-20260520.htm"},"events":[{"id":9929,"run_id":8704,"accession_number":"0001635088-26-000060","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses a press release announcing financial results for the fourth quarter and fiscal year ended March 31, 2026, attached as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which is material to investors as it provides periodic financial performance information.","company_name":"Roivant Sciences Ltd.","ticker":"ROIV","filing_date":"2026-05-20","form":"8-K","submitted_at":null,"items":[{"id":759,"accession_number":"0001635088-26-000060","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a press release announcing financial results for the fourth quarter and fiscal year ended March 31, 2026, attached as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which is material to investors as it provides periodic financial performance information.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:56:13.699652+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":759,"accession_number":"0001635088-26-000060","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a press release announcing financial results for the fourth quarter and fiscal year ended March 31, 2026, attached as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which is material to investors as it provides periodic financial performance information.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:56:13.699652+00:00","company_name":"Roivant Sciences Ltd.","ticker":"ROIV","filing_date":"2026-05-20"}]}